IP Library Patent Application 17841987
Patent Application
App. No. 17/841,987

METHODS AND COMPOSITIONS FOR INCREASING CIRCULATION DURING TREATMENT WITH ALTERNATING ELECTRIC FIELDS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/841,987
Abstract

Disclosed are methods of increasing blood circulation at a target site of a subject comprising exposing a target site of the subject to an alternating electric field for a period of time, the alternating electric field having a frequency and field strength, and exposing the target site of the subject to a vasodilator, wherein the vasodilator increases blood circulation at the target site of the subject. Disclosed are methods of maintaining or decreasing temperature at a target site of a subject comprising exposing a target site of the subject to an alternating electric field for a period of time, the alternating electric field having a frequency and field strength, and exposing the target site of the subject to a vasodilator, wherein the vasodilator increases circulation at the target site of the subject, wherein increased circulation maintains or decreases temperature at the target site.

Claims (25)

1 . A method of increasing blood circulation at a target site of a subject comprising:

a. exposing a target site of the subject to an alternating electric field for a period of time, the alternating electric field having a frequency and field strength, and

b. contacting the target site of the subject to a vasodilator, wherein the vasodilator increases circulation at the target site of the subject.

2 . The method of claim 1 , wherein the frequency of the alternating electric field is between 100 and 500 kHz.

3 . The method of claim 1 , wherein the frequency of the alternating electric field is between 180 and 220 kHz.

4 . The method of claim 1 , wherein the target site comprises a cancer cell.

5 . The method of claim 1 , wherein the cancer cell is a glioblastoma cell or lung metastatic carcinoma cell.

6 . The method of claim 1 , wherein the target site is exposed to the alternating electric field and vasodilator simultaneously.

7 . The method of claim 1 , wherein the target site is exposed to the alternating electric field and vasodilator consecutively.

8 . The method of claim 1 , wherein the vasodilator is nitroprusside, nitroglycerin, minoxidil, or hydralazine.

9 . The method of claim 1 , wherein the increase in blood circulation is 1% greater than blood circulation prior to exposure to the vasodilator.

10 . The method of claim 1 , wherein contacting the target site of the subject to a vasodilator comprises transdermal administration of the vasodilator to the subject at the target site.

11 . The method of claim 1 , wherein the target site is the subject's head, chest, or extremity.

12 . A method of maintaining or decreasing temperature at a target site of a subject comprising:

a. exposing a target site of the subject to an alternating electric field for a period of time, the alternating electric field having a frequency and field strength, and

b. contacting the target site of the subject to a vasodilator,

wherein the vasodilator increases circulation at the target site of the subject, wherein increased circulation maintains or decreases temperature at the target site.

13 . The method of claim 12 , wherein the frequency of the alternating electric field is between 100 and 500 kHz.

14 . The method of claim 12 , wherein the target site comprises a cancer cell.

15 .- 17 .

18 . A method of treating cancer in a subject comprising

a. exposing a target site of the subject to an alternating electric field for a period of time, the alternating electric field having a frequency and field strength, and

b. contacting the target site of the subject to a vasodilator, wherein the vasodilator increases circulation at the target site of the subject,

wherein the target site comprises one or more cancer cells.

19 . The method of claim 18 , wherein the frequency of the alternating electric field is between 100 and 500 kHz.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2023
From: FARBER, ORI
To: NOVOCURE GMBH
Reel/Frame 062267/0039 →